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Abstract
In this paper, we study two-dimensional, three-dimensional monotonic and non-
monotonic immune responses in viral infection systems. Our results show that the viral
infection systems with monotonic immune response has no bistability appear. However,
the systems with nonmonotonic immune response has bistability appear under some
conditions. For immune intensity, we got two important thresholds, post-treatment
control threshold and elite control threshold. When immune intensity is less than
post-treatment control threshold, the virus will be rebound. The virus will be under
control when immune intensity is larger than elite control threshold. While between
the two thresholds is a bistable interval. When immune intensity is in the bistable
interval, the system can have bistability appear. Select the rate of immune cells stim-
ulated by the viruses as a bifurcation parameter for nonmonotonic immune responses,
we prove the system exhibits saddle-node bifurcation and transcritical bifurcation.
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1. Introduction
During the process of viral infection, the host is induced which is initially rapid and
nonspecific (natural killer cells, macrophage cells, etc.) and then delayed and specific
(cytotoxic T lymphocyte cells, antibody cell). But in most virus infections, cytotoxic
T lymphocyte (CTL) cells which attack infected cells and antibody cells which attack
viruses, play a critical part in antiviral defense. Some researchers have studied some
models about virus dynamics within-host and immune response, [1, 2, 3, 4, 5] and
others don’t contain the immune responses. [6, 7, 8, 9, 10, 11]
In order to investigate the role of the population dynamics of viral infection with
CTL response, Nowak and Bangham (see e.g. Refs [12]) constructed a mathematical
model describing the basic dynamics of the interaction between activated CD4+ T cells,
x(t), infected CD4+ T cells, y(t), viruses, v(t) and immune cells, z(t).

dx
dt
= s− dx− (1− ǫ)βxy,
dy
dt
= (1− ǫ)βxy − ay − pyz,
dz
dt
= f(y)z − bz,
(1.1)
where f(y) is a continuously differentiable function defined on [0,+∞) and satisfies
f
′
(y) > 0, f(0) = 0 and f(y) ≤My for some positive parameter M. (1.2)
For example, f(y) = cy or f(y) = cy
1+αy
is the common monotonic immune response
in viral infection systems. [15, 16] In 1968, Andrews (see e.g. Refs [13]) suggested
Monod-Haldane function
f(y) =
cy
α + γy + y2
,
then, Sokol and Howell (see e.g. Refs [14]) proposed a simplified Monod-Haldane
function
f(y) =
cy
α + y2
,
as nonmonotonic functions in chemostat systems. The nonmonotonic functions are also
discussed in predator-prey system. [17, 18, 19] Wang et al (see e.g. Refs [20]) proposed
oxidative stress in a HIV infection model and the immune function is a Monod-Haldane
function. Thus we chose cyz
α+γy+y2
as the nonmonotonic immune response in the following
system. 

dx
dt
= s− dx− (1− ǫ)βxy = g1,
dy
dt
= (1− ǫ)βxy − ay − pyz = g2,
dz
dt
= cyz
α+γy+y2
− bz = g3.
(1.3)
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Activated CD4+ T cells are generated at a rate s, die at a rate d, and become infected
CD4+ T cells at a rate (1− ǫ)βxy. Infected CD4+ T cells die at a rate a and are killed
by immune cells at a rate pyz. cyz
α+γy+y2
represents the immune cells stimulated by the
viruses and die at a rate b. All the parameters are positive.
The rest of this paper is organized as follows. The viral infection system with
monotonic immune response is carried out in section 2. The stability analysis, bifurca-
tion analysis and numerical simulations of nonmonotonic immune response is carried
out in Section 3. In section 4, we analyze the 2D-viral infection system with mono-
tonic immune response. In section 5, we analyze the stability and bifurcation of the
2D-viral infection system with monotonic immune response and carry out numerical
simulations. In section 6, we conclude the paper with discussions.
2. Viral infection system with monotonic immune response
System (1.1) always has an uninfected steady equilibrium E
(1)
0 = (x
(1)
0 , 0, 0), and if
R(1)0 > 1 > R(1)∗ , system (1.1) also has an immune-free equilibrium E(1)1 = (x(1)1 , y(1)1 , 0);
IfR(1)0 > R(1)∗ > 1 system (1.1) has three equilibria E(1)0 , E(1)1 and E(1)∗ = (x(1)∗ , y(1)∗ , z(1)∗ ),
where
x
(1)
0 =
s
d
,
x
(1)
1 =
a
β(1−ǫ) ,
y
(1)
1 =
d(R
(1)
0 −1)
β(1−ǫ) ,
x
(1)
∗ = s
d+(1−ǫ)βy(1)∗
,
y(1)∗ = f
−1(b),
z(1)∗ =
a(R
(1)
∗ − 1)
p
.
The basic reproductive number is given as
R(1)0 = (1− ǫ)β
s
d
1
a
1 =
sβ(1− ǫ)
ad
.
Because (1−ǫ)β s
d
1
a
is the basic reproductive number of the model with the bilinear inci-
dence βxy, R
(1)
0 gives the basic reproductive number of system (1.1) with the constant
function response.
The basic immune reproductive number is
R(1)∗ =
sβ(1− ǫ)
ad+ aβ(1− ǫ)y(1)∗
.
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This ratio describes the average number of newly infected cells generated form on
infected cells at the beginning of the infectious process.
Let E˜ be any arbitrary equilibrium of system (1.1). The Jacobian matrix associated
with the system is
J1 =


−d − β(1− ǫ)y −β(1− ǫ)x 0
β(1− ǫ)y β(1− ǫ)x− a− pz −py
0 f
′
(y)z f(y)− b

 .
The characteristic equation of the linearized system of (1.1) at E˜ is given by |λI − J1| =
0.
Lemma 2.1 R(1)∗ < 1⇔ y(1)1 < y(1)∗ .
Proof.
R(1)∗ < 1 ⇔ (1−ǫ)βs
ad+(1−ǫ)aβy(1)∗
< 1,
⇔ R(1)0 < 1 + (1−ǫ)βy
(1)
∗
d
⇔ d(R
(1)
0 −1)
β(1−ǫ) < y
(1)
∗
⇔ y(1)1 < y(1)∗ .

Theorem 2.1 If R(1)0 < 1, then the uninfected equilibrium E(1)0 of system (1.1) is not
only locally asymptotically stable, but also global asymptotically stable. If R(1)0 > 1,
then the uninfected equilibrium E
(1)
0 of system (1.1) is unstable.
Proof. The characteristic equation of the linearized system of system (1.1) at E
(1)
0 is
(λ+ b)(λ + d)(λ+ a− (1− ǫ)βx(1)0 ) = 0.
Obviously, the characteristic roots −d, −b, and a(R(1)0 − 1) are negative for R(1)0 < 1.
Hence E
(1)
0 is locally asymptotically stable. If R(1)0 > 1, then a(R(1)0 −1) > 0, thus, the
uninfected equilibrium E
(1)
0 of system (1.1) is unstable.
Consider the Lyapunov function
V0 =
1
2
(x− x(1)0 )2 + x(1)0 y +
px
(1)
0
M
z.
Differentiating V0 along solutions of system (1.1) yields
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V˙0|(1.1) = (x− x(1)0 )[s− dx− (1− ǫ)βxy] + x(1)0 [(1− ǫ)βxy − ay − pyz]
+
px
(1)
0
M
[f(y)z − bz]
= (x− x(1)0 )[dx(1)0 − dx− (1− ǫ)βxy] + x(1)0 [(1− ǫ)βxy − ay − pyz]
+
px
(1)
0
M
f(y)z − px
(1)
0
M
bz
≤ −d(x− x(1)0 )2 − (1− ǫ)βx2y + 2(1− ǫ)βx(1)0 xy − ax(1)0 y −
px
(1)
0
M
bz
= −[d+ (1− ǫ)βy](x− x(1)0 )2 − ax(1)0 y(1−R(1)0 )−
px
(1)
0
M
bz.
If R
(1)
0 < 1, then V˙0|(1.1) ≤ 0. Furthermore,
W0 = {(x, y, z)|V˙0 = 0} = {(x, y, z)|x = x(1)0 , y = 0, z = 0}.
Therefore, the largest invariant set contained in W0 is E
(1)
0 . By LaSalle
′s invariance
principle, [22, 23] we infer that all the solutions of system (1.1) that start in R3 > 0 limit
to E
(1)
0 . Besides, E
(1)
0 is Lyapunov stable, prove that E
(1)
0 is globally asymptotically
stable. Theorem 2.1 is proved. 
Theorem 2.2 If R(1)0 > 1 > R(1)∗ , then the immune-free equilibrium E(1)1 of system
(1.1) is locally asymptotically stable. E
(1)
1 is unstable for R(1)∗ > 1.
Proof. The characteristic equation of the linearized system of (1.1) at E
(1)
1 is given by
[λ− (f(y(1)1 )− b)][λ2 + a(1)1 λ+ a(1)2 ] = 0,
where
a
(1)
1 = d+ (1− ǫ)βy(1)1 ,
a
(1)
2 = (1− ǫ)2β2x(1)1 y(1)1 .
By (1.2), f
′
(y) > 0 for [0,+∞) and f(y(1)∗ ) = b, we deduce the eigenvalue λ = f(y(1)1 )−
b < 0 for R(1)0 > 1 > R(1)∗ , and λ = f(y(1)1 )− b > 0 for R(1)∗ > 1. a(1)1 > 0 and a(1)2 > 0
inducing, the other eigenvalues are negative. Thus, the immune-free equilibrium E
(1)
1
of system (1.1) is locally asymptotically stable for R(1)0 > 1 > R(1)∗ and E(1)1 is unstable
for R
(1)
∗ > 1. 
Theorem 2.3 If R(1)∗ > 1, then the positive equilibrium E(1)∗ of system (1.1) is locally
asymptotically stable.
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Proof. The characteristic equation of the linearized system of (1.1) at E
(1)
∗ is given by
λ3 + b
(1)
1 λ
2 + b
(1)
2 λ+ b
(1)
3 = 0,
where
b
(1)
1 = d+ (1− ǫ)βy(1)∗ ,
b
(1)
2 = py
(1)
∗ z
(1)
∗ f
′
(y
(1)
∗ ) + (1− ǫ)2β2x(1)∗ y(1)∗ ,
b
(1)
3 = py
(1)
∗ z
(1)
∗ f
′
(y
(1)
∗ )[d+ (1− ǫ)βy(1)∗ ].
It is easy to see, b
(1)
i > 0(i = 1, 2, 3) and b
(1)
1 b
(1)
2 − b(1)3 = (1 − ǫ)2β2x(1)∗ y(1)∗ [d + (1 −
ǫ)βy
(1)
∗ ] > 0. By Routh-Hurartz Criterion, we know the positive equilibrium E
(1)
∗ of
system (1.1) is locally asymptotically stable for R(1)∗ > 1. 
By Theorem 2.1∼2.3, we can get following result:
Remark 2.1 Viral infection system with monotonic immune response has no bista-
bility appear.
3. Viral infection system with nonmonotonic immune response
3.1. Equilibria and thresholds
In this section, we discuss the viral infection system with nonmonotonic immune
response (1.3) and always assume γ > 2
√
α. We denote basic reproductive number
R
(2)
0 =
sβ(1−ǫ)
ad
, which is equivalent to R
(1)
0 .
(i) If R(2)0 < 1, system (1.3) only exists an uninfected equilibrium E(2)0 = (x(2)0 , 0, 0)
, where x
(2)
0 =
s
d
.
(ii) IfR(2)0 > 1, system (1.3) also has an immune-free equilibrium E(2)1 = (x(2)1 , y(2)1 , 0),
where x
(2)
1 =
a
β(1−ǫ) , y
(2)
1 =
d(R
(2)
0 −1)
β(1−ǫ) .
Solving equation cy
α+γy+y2
− b = 0, one get two positive roots, c1 = γb − 2b
√
α and
c2 = γb+ 2b
√
α , then the existence conditions of positive equilibria as following:
(iii) If R1−∗ > 1 and c > c2, system (1.3) has an immune equilibrium E2−∗ =
(x2−∗ , y
2−
∗ , z
2−
∗ ); If R1+∗ > 1 and c > c2, system (1.3) also has an immune equilibrium
E2+∗ = (x
2+
∗ , y
2+
∗ , z
2+
∗ ). HereR1±∗ = (1−ǫ)βs−ad(1−ǫ)βay2±∗ , x
2±
∗ =
s
(1−ǫ)βy2±∗ +d
, y2±∗ =
−B±
√
B2−4αb2
2b
, z2±∗ =
(1−ǫ)βay2±∗ (R1±∗ −1)
p[(1−ǫ)βy2±∗ +d]
, B = γb− c.
We denote post-treatment control threshold PI (see e.g. Refs [21])
c2 = γb+ 2b
√
α.
Denote
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c∗1 = γb+
2bd(R(2)0 − 1)
β(1− ǫ) ,
c∗∗1 = γb+
bd(R(2)0 − 1)
β(1− ǫ) +
αβb(1− ǫ)
d(R(2)0 − 1)
.
We call c∗∗1 the elite control threshold E1, [21] which means the virus will be under
control when the immune intensity c is larger than c∗∗1 .
Denote another threshold
R(1)c = 1 +
β(1− ǫ)
d
√
α.
For the positive parameters in model (1.3), we have the following lemmas.
Lemma 3.1 R(2)0 > R(1)c > 1⇔ c∗1 > c∗∗1 .
Proof.
c∗1 > c
∗∗
1 ⇔ bd(R
(2)
0 −1)
β(1−ǫ) >
αβb(1−ǫ)
d(R(2)0 −1)
,
⇔ R(2)0 > R(1)c .

Lemma 3.2 (i) R(2)0 > R(1)c > 1⇔ c∗1 > c2; (ii) 1 < R(2)0 < R(1)c ⇔ c∗1 < c2.
Proof.
c∗1 > c2 ⇔ 2bd(R
(2)
0 −1)
β(1−ǫ) > 2b
√
α,
⇔ R(2)0 > R(1)c .
c∗1 < c2 ⇔ 2bd(R
(2)
0 −1)
β(1−ǫ) < 2b
√
α,
⇔ R(2)0 < R(1)c .

Lemma 3.3 (i) Assume 1 < R(2)0 < R(1)c . If R1−∗ > 1, then c > c∗∗1 ; (ii) Assume
R(2)0 > R(1)c > 1. If R1−∗ > 1, then c > c2.
Proof.
R1−∗ > 1 ⇔ βs(1−ǫ)−adβa(1−ǫ)y2−∗ > 1,
⇔ √(γb− c)2 − 4αb2 > c− c∗1.
If c < c∗1 and one of conditions c < c1 or c > c2 is correct, then R1−∗ is always larger
than one. If c > c∗1, solving
√
(γb− c)2 − 4αb2 > c− c∗1, we have c > c∗∗1 . Thus,
(i) If 1 < R(2)0 < R(1)c , then c∗1 < c2. From R1−∗ > 1, we have c > c∗∗1 .
(ii) If R(2)0 > R(1)c > 1, then c∗1 > c2. From R1−∗ > 1, we have c > c2. 
Lemma 3.4 (i) If 1 < R(2)0 < R(1)c , then R1+∗ > 1 has no solution; (ii) Assume
R(2)0 > R(1)c > 1. If R1+∗ > 1, then c2 < c < c∗∗1 .
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Proof.
R1+∗ > 1 ⇔ βs(1−ǫ)−adβa(1−ǫ)y2+∗ > 1,
⇔ c∗1 − c >
√
(γb− c)2 − 4αb2.
(i) If 1 < R
(2)
0 < R
(1)
c , then c∗1 < c2. Thus R1+∗ > 1 has no solution. (ii) If
R(2)0 > R(1)c > 1, then c∗1 > c2. Solving R1+∗ > 1, we have c2 < c < c∗∗1 . 
By Lemma 3.1 ∼ Lemma 3.4 and summing up the above analysis we obtain the
existing results of equilibria of system (1.3).
Theorem 3.1 (i) System (1.3) always exists an uninfected equilibrium E
(2)
0 ;
(ii) If R(2)0 > 1, system (1.3) also has an immune-free equilibrium E(2)1 ;
(iii) If 1 < R(2)0 < R(1)c and c > c∗∗1 , system (1.3) also has one positive equilibrium
E2−∗ ;
(iv) If R(2)0 > R(1)c > 1 and c2 < c < c∗∗1 , system (1.3) has two positive equilibria
E2+∗ and E
2−
∗ . While R(2)0 > R(1)c and c > c∗∗1 , system (1.3) only has one positive
equilibrium E2−∗ ;
The summary results of the existence for positive equilibria can be seen in Table 1
and Table 2.
3.2. Stability analysis
Let E˜ be any arbitrary equilibrium of system (1.3). The Jacobian matrix associated
with the system is
J2 =


−d− β(1− ǫ)y −β(1− ǫ)x 0
β(1− ǫ)y β(1− ǫ)x− a− pz −py
0 cαz−czy
2
(α+γy+y2)2
cy
α+γy+y2
− b

 .
The characteristic equation of the linearized system of (1.3) at E˜ is given by |λI − J2| =
0.
Theorem 3.2 If R(2)0 < 1, then the uninfected equilibrium E(2)0 of system (1.3) is
not only locally asymptotically stable, but also global asymptotically stable.
Proof. The characteristic roots of the linearized system of (1.3) at E
(2)
0 is given by
λ1 = −d, λ2 = −b and λ3 = R
(2)
0 −1
a
. So we can get R(2)0 < 1 , the uninfected equilibrium
E
(2)
0 is locally asymptotically stable.
Consider the Lyapunov function
V1 =
1
2
(x− x(2)0 )2 + x(2)0 y +
αpx
(2)
0
c
z.
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Differentiating V1 along solutions of system (1.3) yields
V˙1|(1.3) = (x− x(2)0 )[s− dx− (1− ǫ)βxy] + x(2)0 [(1− ǫ)βxy − ay − pyz]
+
αpx
(2)
0
c
[
cyz
α + γy + y2
− bz]
= (x− x(2)0 )[dx(2)0 − dx− (1− ǫ)βxy] + x(2)0 [(1− ǫ)βxy − ay − pyz]
+
αpx
(2)
0 yz
α + γy + y2
− αbpx
(2)
0
c
z
≤ −d(x− x(2)0 )2 − (1− ǫ)βx2y + 2(1− ǫ)βx(2)0 xy − ax(2)0 y −
αbpx
(2)
0
c
z
= −[d + (1− ǫ)βy](x− x(2)0 )2 − ax(2)0 y(1− R(2)0 )−
αbpx
(2)
0
c
z.
If R
(2)
0 < 1, then V˙1|(1.3) ≤ 0.
Furthermore,
W1 = {(x, y, z)|V˙1 = 0} = {(x, y, z)|x = x(2)0 , y = 0, z = 0}.
Therefore, the largest invariant set contained in W1 is E
(2)
0 . By LaSalle
′s invariance
principle, [22, 23] we infer that all the solutions of system (1.3) that start in R3 > 0 limit
to E
(2)
0 . Besides, E
(2)
0 is Lyapunov stable, prove that E
(2)
0 is globally asymptotically
stable. Theorem 3.2 is proved. 
Theorem 3.3 Suppose R(2)0 > 1. When 0 < c < c∗∗1 , E(2)1 is locally asymptotically
stable. When c > c∗∗1 , E
(2)
1 is unstable.
Proof. The characteristic equation of the linearized system of (1.3) at E
(2)
1 is given by
[λ− ( cy
(2)
1
α+γy
(2)
1 +(y
(2)
1 )
2
− b)][λ2 + a(2)1 λ+ a(2)2 ] = 0,
where
a
(2)
1 = (1− ǫ)βy(2)1 + d > 0,
a
(2)
2 = (1− ǫ)2β2x(2)1 y(2)1 > 0.
Another eigenvalue
λ =
cy
(2)
1
α+γy
(2)
1 +(y
(2)
1 )
2
− b < 0 ⇔ c < c∗∗1 .
In summary, if 0 < c < c∗∗1 , then λ < 0. Therefore, by Routh-Hurartz criterion, we
know under the assumption of R(2)0 > 1. If 0 < c < c∗∗1 , the equilibrium E(2)1 of system
(1.3) is locally asymptotically stable. If c > c∗∗1 , E
(2)
1 is unstable. 
Theorem 3.4 (i) If (A.1) 1 < R(2)0 < R(1)c and c > c∗∗1 , or
9
(A.2) R(2)0 > R(1)c and c > c2,
system (1.3) has an immune equilibrium E2−∗ , which is a stable node.
(ii) If R(2)0 > R(1)c and c2 < c < c∗∗1 , system (1.3) also has an immune equilibrium
E2+∗ , which is an unstable saddle.
Proof. Denote E
(2)
∗ = (x
(2)
∗ , y
(2)
∗ , z
(2)
∗ ) as an arbitrary positive equilibrium of system
(1.3). The characteristic equation of the linearized system of (1.3) at the arbitrary
positive equilibrium E
(2)
∗ is given by
λ3 + b
(2)
1 λ
2 + b
(2)
2 λ+ b
(2)
3 = 0,
where
b
(2)
1 = (1− ǫ)βy(2)∗ + d > 0,
b
(2)
2 = (1− ǫ)2β2x(2)∗ y(2)∗ + cpy(2)∗ z(2)∗ α−(y
(2)
∗ )2
(α+γy
(2)
∗ +(y
(2)
∗ )2)2
,
b
(2)
3 = cpy
(2)
∗ z
(2)
∗ [(1− ǫ)βy(2)∗ + d] α−(y
(2)
∗ )2
(α+γy
(2)
∗ +(y
(2)
∗ )2)2
,
and
b
(2)
1 b
(2)
2 − b(2)3 = [(1− ǫ)βy(2)∗ + d](1− ǫ)2β2x(2)∗ y(2)∗ > 0.
For equilibrium E2−∗ ,
α− (y2−∗ )2 > 0 ⇔ −B−
√
B2−4αb2
2b
<
√
α,
⇔ c > c2.
If c > c2, we can get b
(2)
2 > 0 and b
(2)
3 > 0, by Routh-Hurartz Criterion, we know in
this case the positive equilibrium E2−∗ is a stable node.
For equilibrium E2+∗ ,
α− (y2+∗ )2 < 0 ⇔ −B+
√
B2−4αb2
2b
>
√
α,
⇔ √B2 − 4αb2 > B + 2b√α.
When c2 < c < c
∗∗
1 , then b
(2)
3 < 0, so the immune equilibrium E
2+
∗ is an unstable saddle.

3.3. Saddle-node bifurcation
If R(2)0 > R(1)c > 1 and c2 − 2γbc + γ2b2 − 4αb2 = 0, the immune equilibrium E2+∗
and E2−∗ coincide with each other. Then system has the unique interior equilibrium
E
(2)
∗ = (x
(2)
∗ , y
(2)
∗ , z
(2)
∗ ) = ( s(1−ǫ)βα+d ,
√
α, 1
p
( (1−ǫ)βs
(1−ǫ)βα+d−a). If c < c[sn], there is no positive
equilibrium and there is two positive equilibria. Thus, system (1.3) will be a saddle-
node bifurcation when c crosses the bifurcation value c[sn], where c[sn] = γb+ 2b
√
α.
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Theorem 3.5 If R(2)0 > R(1)c > 1 and c = c[sn], system (1.3) undergoes a saddle-node
bifurcation.
Proof. We use Sotomayor’s theorem [26, 27, 28] to prove system (1.3) undergoes a
saddle-node bifurcation at c = c[sn]. It can be easy to prove Det[J
E
(2)
∗
] = 0, so one of
the eigenvalue of the Jacobian at the saddle-node equilibrium is zero, where J = J2.
Let ϕ = (ϕ1, ϕ2, ϕ3)
T and ψ = (ψ1, ψ2, ψ3)
T represent the eigenvectors of J
E
(2)
∗
and JT
E
(2)
∗
corresponding to the zero eigenvalue, respectively, then they are given by
ϕ = (1, −d−β(1−ǫ)y
(2)
∗
β(1−ǫ)x(2)∗
, β(1−ǫ)
p
)T and ψ = (0, 0, 1)T. Let G = (g1, g2, g3), we can get
Gc(E
(2)
∗ ; c
[sn]) =


0
0
yz
α+γy+y2


(E
(2)
∗ ;c[sn])
=


0
0
√
αz
(2)
∗
2α+γ
√
α

 ,
D2G(E(2)∗ ; c
[sn])(ϕ, ϕ)
=


2(d+β(1−ǫ)y)
x
0
(−6cαyz+2czy3−2cαγz)(d+β(1−ǫ)y)2
β2(1−ǫ)2x2(α+γy+y2)3 − 2cβ(1−ǫ)(d+β(1−ǫ)y)(α−y
2)
pxβ(1−ǫ)(α+γy+y2)2


(E∗;c[sn])
=


2(d+β(1−ǫ)√α)
x
(2)
∗
0
2αz
(2)
∗ (γb+2b
√
α)(d+β
√
α(1−ǫ))2
β2x
(2)
∗
2
(1−ǫ)2(2α+γ√α)3

 .
Therefore,
Ψ1 = ψ
TGc(E
(2)
∗ , c
[sn]) =
√
αz
(2)
∗
2α + γ
√
α
6= 0,
Ψ2 = ψ
T[D2G(E(2)∗ ; c
[sn])(ϕ, ϕ)] =
2αz
(2)
∗ (γb+ 2b
√
α)(d+ β
√
α(1− ǫ))2
β2x
(2)
∗
2
(1− ǫ)2(2α+ γ√α)3
6= 0.
Therefore, system (1.3) undergoes a saddle-node bifurcation at E
(2)
∗ when c = c[sn].
If c < c[sn], there is no positive equilibrium. If c > c[sn], there is two positive equilibria.
3.4. Transcritical Bifurcation
If c = γb +
bd(R(2)0 −1)
1−ǫ +
αβb(1−ǫ)
d(R(2)0 −1)
, the boundary equilibrium E
(2)
1 looses its stability
and one of the eigenvalue of the Jacobian at E
(2)
1 is zero. Hence, bifurcation may
11
occur at the boundary equilibrium E
(2)
1 . Next we study the existence of a transcritical
bifurcation and select parameter c as bifurcation parameter.
Theorem 5.6 If R0 > 1 and c = c
[tc], system (1.3) will undergoes a transcritical
bifurcation at E
(2)
1 , c as the bifurcation parameter and c
[tc] as the bifurcation threshold
is given by c = c[tc] = γb+
bd(R(2)0 −1)
β(1−ǫ) +
αβb(1−ǫ)
d(R(2)0 −1)
.
Proof. We also use Sotomayor’s theorem [26, 27, 28] to prove system (1.3) undergoes
a transcritical bifurcation. It is clear that one of the eigenvalue of the Jacobian at E
(2)
1
is zero, if and only if c = c[tc].
Let η = (η1, η2, η3)
T and θ = (θ1, θ2, θ3)
T denote the eigenvectors of J
E
(2)
1
and JT
E
(2)
1
corresponding to the zero eigenvalue, respectively, we can get η = (1,
−d−β(1−ǫ)y(2)1
β(1−ǫ)x(2)1
, β(1−ǫ)
p
)T
and θ = (0, 0, 1)T, Besides,
Gc(E
(2)
1 ; c
[tc]) =


0
0
yz
α+γy+y2


(E
(2)
1 ;c
[tc])
=


0
0
0

 .
DGc(E
(2)
1 ; c
[tc])η
=


0
0
− (d+β(1−ǫ)y)(α−y2)z
βx(1−ǫ)(α+γy+y2)2 +
βy(1−ǫ)
p(α+γy+y2)


(E
(2)
1 ;c
[tc])
=


0
0
βy
(2)
1 (1−ǫ)
p(α+γy
(2)
1 +y
(2)
1
2
)

 .
D2G(E
(2)
1 ; c
[sn])(η, η)
=


2(d+β(1−ǫ)y)
x
0
(−6cαyz+2czy3−2cαγz)(d+β(1−ǫ)y)2
β2(1−ǫ)2x2(α+γy+y2)3 − 2cβ(1−ǫ)(d+β(1−ǫ)y)(α−y
2)
pxβ(1−ǫ)(α+γy+y2)2


(E
(2)
1 ;c
[sn])
=


2(d+β(1−ǫ)√α)
x
(2)
1
0
−2cβ(1−ǫ)(d+β(1−ǫ)y
(2)
1 )(α−y
(2)
1
2
)
px
(2)
1 β(1−ǫ)(α+γy
(2)
1 +y
(2)
1
2
)2

 .
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Therefore,
Γ1 = θ
TGc(E
(2)
1 ; c
[tc]) = 0,
Γ2 = θ
T[DGc(E
(2)
1 ; c
[tc])η] =
βy
(2)
1 (1− ǫ)
p(α+ γy
(2)
1 + y
(2)
1
2
)
6= 0
Γ3 = θ
T[D2G(E
(2)
1 ; c
[tc])(η, η)] = −2cβ(1− ǫ)(d+ β(1− ǫ)y
(2)
1 )(α− y(2)1
2
)
px
(2)
1 β(1− ǫ)(α + γy(2)1 + y(2)1
2
)2
6= 0.
Therefore, system (1.3) will undergoes a transcritical bifurcation between E
(2)
1 when
c = c[tc]

Remark 3.1 If R(2)0 > R(1)c > 1 and c2 < c < c∗∗1 , system (1.3) has bistability appear.
In other cases, system (1.3) has no bistability appear. Threshold c2 is a post-treatment
control threshold, c∗∗1 is a elite control threshold. (c2, c
∗∗
1 ) is a bistable interval.
To sum up, the stabilities of the equilibria and the behaviors of system (1.3) can
be shown in Table 3 and Table 4.
3.5. Numerical simulations and discussion
To verify our analysis results, we carry out some numerical simulations choosing
some parameter values shown as in [21, 24? ]:
s = 10 cells/µl/day, d = 0.01 day−1, ǫ = 0.9,
β = 0.015 µl/day, a = 1.1 day−1, p = 0.5 day−1,
α = 1 cells/µl, γ = 1 cells/µl, b = 0.1 day−1.
(3.1)
The parameters chose as same as in (3.1), the thresholds R(2)0 ≈ 1.3636, R(1)c =
1.1500, post-treatment control threshold c2 = 0.3000 and elite control threshold c
∗∗
1 ≈
0.3837. In this case, R(2)0 > R(1)c and c2 < c∗∗1 , then we get a bistable interval
(0.3000, 0.3837) (see Figure 1). When 0 < c < c2, the immune-free equilibrium E
(2)
1
is stable (see Fig. 2); When c2 < c < c
∗∗
1 , the immune-free equilibrium E
(2)
1 and the
positive equilibrium E2−∗ are stable (see Fig. 3); When c > c
∗∗
1 , only the positive
equilibrium E2−∗ is stable (see Figure 4).
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Figure 1: Bistability and saddle-node bifurcation diagram of system (1.3). The solid line is the
stable infected CD4+ T cells and the dashed line depends the unstable infected CD4+ T cells. The
post-treatment control threshold is c2 = 0.2500, the elite control threshold is c
∗∗
1 ≈ 0.6505 and the
bistable interval is (0.2500, 0.6505). c = 0.37 day−1 and other parameter values are shown in (3.1).
Figure 2: System (1.3) has a stable equilibria E(2)1 . Parameter c = 0.2 day
−1 less than post-
treatment control threshold PI and other parameter values are shown in (3.1). We choose different
initial values.
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Figure 3: System (1.3) has two different stable equilibria E(2)1 and E
2∗
−
. Parameter c = 0.37 day−1
and other parameter values are shown in (3.1). We choose different initial values.
4. 2D-Viral infection system with monotonic immune response
In this section, we discuss 2D viral infection system with monotonic immune re-
sponse. {
dy
dt
= γy(1− y
K
)− ay − pyz = P1,
dz
dt
= f(y)z − bz = Q1,
(4.1)
where f(y) is a monotonic function of y and satisfies (1.2).
System (4.1) always has an uninfected steady equilibrium E
(3)
0 = (0, 0), and if
R
(2)
0 > 1, system (4.1) also has an immune-free equilibrium E
(3)
1 = (y
(3)
1 , 0); If R(2)∗ > 1
system (4.1) has three equilibria E
(3)
0 , E
(3)
1 and E
(3)
∗ = (y
(3)
∗ , z
(3)
∗ ), where
y
(3)
1 =
aK
γ
(R
(3)
0 − 1),
y
(3)
∗ = f−1(b),
z(3)∗ =
a
p
(R(2)∗ − 1).
We give a threshold
R(3)0 =
γ
a
,
15
0 1 2 3 4 5 6 7
Days ×104
600
700
800
900
1000
x
/A
c
ti
v
a
te
d
 C
D
4
+
 
T
 c
e
ll
s
0 1 2 3 4 5 6 7
Days ×104
0
5
10
15
20
y
/ 
In
fe
c
te
d
 C
D
4
+
 
T
 c
e
ll
s
0 1 2 3 4 5 6 7
Days ×104
0
0.5
1
1.5
z
/I
m
m
u
n
e
 c
e
ll
s
Figure 4: System (1.3) has only the positive equilibrium E2∗
−
is stable. Parameter c = 0.65 day−1
and other parameter values are shown in (3.1). We choose different initial values.
and the basic immune reproductive number is
R(2)∗ =
γ
a
(1− y
(3)
∗
K
).
This ratio describes the average number of newly infected cells generated form on
infected cell at the beginning of the infectious process.
Let E˜ be any arbitrary equilibrium of system (4.1). The Jacobian matrix associated
with the system is
J3 =
[
γ − a− 2γ
k
y˜ − pz˜ −py˜
f
′
(y˜)z˜ f(y˜)− b
]
.
The characteristic equation of the linearized system of (4.1) at E˜ is given by |λI − J3| =
0.
Lemma 4.1 R(2)∗ < 1⇔ y(3)1 < y(3)∗ .
Proof.
R
(2)
∗ < 1 ⇔ γa (1− y
(3)
∗
K
) < 1,
⇔ Ka
γ
(R
(3)
0 − 1) < y(3)∗ ,
⇔ y(3)1 < y(3)∗ .

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Lemma 4.2 System (4.1) has no limit cycles in the interior of the first quadrant.
Proof. Consider the Dulac function
D1 =
1
yz
.
We can get
∂(D1P1)
∂y
+
∂(D1Q1)
∂z
=
∂[ 1
yz
(γy(1− y
K
)− ay − pyz)]
∂y
+
∂[ 1
yz
(f(y)z − bz)]
∂z
=
∂(γ
z
− γy
Kz
− a
z
− p)
∂y
+
∂(f(y)
y
− b
y
)
∂z
= − γ
Kz
≤ 0.
By Bendixson−Dulac discriminant method, we know system (4.1) has no limit cycles.

Theorem 4.1 If R(3)0 < 1, then the uninfected equilibrium E(3)0 of system (4.1) is not
only locally asymptotically stable, but also global asymptotically stable. If R(3)0 > 1.
then the uninfected equilibrium E
(3)
0 of system (4.1) is unstable.
Proof. The characteristic equation of the linearized system of system (4.1) at E
(3)
0 is
(λ+ a− γ)(λ+ b) = 0.
Obviously, the characteristic roots −b and a(R(3)0 − 1) are negative for R(3)0 < 1.
Hence E
(3)
0 is locally asymptotically stable. If R(3)0 > 1, then a(R(3)0 −1) > 0, thus, the
uninfected equilibrium E
(3)
0 of system (4.1) is unstable. By Lemma 4.2, the uninfected
equilibrium E
(3)
0 is global asymptotically stable. Theorem 4.1 is proved. 
Theorem 4.2 If R(3)0 > 1 > R(2)∗ , then the immune-free equilibrium E(3)1 of system
(4.1) is not only locally asymptotically stable, but also global asymptotically stable.
E
(3)
1 is unstable for R(2)∗ > 1.
Proof. The characteristic equation of the linearized system of (4.1) at E
(3)
1 is given by
(λ+
γ
k
y
(3)
1 )[λ− (f(y(3)1 )− b)] = 0.
By Lemma 4.1 and f
′
(y) > 0 for [0,+∞) and f(y(3)∗ ) = b, we deduce the eigenvalue
λ = f(y
(3)
1 ) − b < 0 for R(3)0 > 1 > R(2)∗ , and λ = f(y(3)1 ) − b > 0 for R(2)∗ > 1.
Thus, the immune-free equilibrium E
(3)
1 of system (4.1) is locally asymptotically stable
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for R(3)0 > 1 > R(2)∗ and is unstable for R(2)∗ > 1. By Lemma 4.2, the immune-free
equilibrium E
(3)
1 is global asymptotically stable. Theorem 4.2 is proved. 
Theorem 4.3 If R(2)∗ > 1, then the positive equilibrium E(3)∗ of system (4.1) is not
only locally asymptotically stable, but also global asymptotically stable.
Proof. The characteristic equation of the linearized system of (4.1) at E
(3)
∗ is given by
λ2 + a
(3)
1 λ+ a
(3)
2 = 0,
where
a
(3)
1 =
γ
k
y
(3)
∗ + b− f(y(3)∗ ),
a
(3)
2 =
γ
k
y
(3)
∗ [b− f(y(3)∗ )] + py(3)∗ z(3)∗ f ′(y(3)∗ ).
By Lemma 4.1 and f
′
(y) > 0 for [0,+∞) and f(y(3)∗ ) = b, we know a(3)1 > 0 and a(3)2 > 0.
By Routh-Hurartz Criterion, we know the positive equilibrium E
(3)
∗ of system (4.1) is
locally asymptotically stable for R(2)∗ > 1. By Lemma 4.2, the positive equilibrium
E
(3)
∗ is global asymptotically stable. Theorem 4.3 is proved. 
By Theorem 4.1∼4.3, we can get following result:
Remark 4.1 Viral infection system with monotonic immune response has no bista-
bility appear.
5. 2D-Viral infection system with nonmonotonic immune response
In this section, we will discuss the 2D-viral infection system with Monod-Haldane
function, which is a system with nonmonotonic immune response.
{
dy
dt
= γy(1− y
K
)− ay − pyz = P2,
dz
dt
= cyz
α+γy+y2
− bz = Q2,
(5.1)
We always assume K >
√
α. The threshold R
(4)
0 =
γ
a
, which is equivalent to R
(3)
0 .
(i) System (5.1) always has an uninfected steady equilibrium E
(4)
0 = (0, 0), and
if R
(4)
0 > 1, system (5.1) also has an immune-free equilibrium E
(4)
1 = (y
(4)
1 , 0), where
y
(4)
1 =
Ka
γ
(R
(4)
0 − 1).
Solving equation cy
α+γy+y2
− b = 0, one get two positive roots, c1 = γb − 2b
√
α and
c2 = γb+ 2b
√
α , then the existence conditions of positive equilibria as following:
(ii) If R2−∗ > 1 and c > c2, system (5.1) has an immune equilibrium E4−∗ =
(y4−∗ , z
4−
∗ ); If R2+∗ > 1 and c > c2, system (1.3) also has an immune equilibrium
E4+∗ = (y
4+
∗ , z
4+
∗ ). Here R2±∗ = γa (1− y
4±
∗
K
), y4±∗ =
−B±
√
B2−4αb2
2b
, z4±∗ =
a
p
(R2±∗ − 1), B =
γb− c.
18
We denote post-treatment control threshold PII (see e.g. Refs [21])
c2 = γb+ 2b
√
α.
Which is equivalent to post-treatment control threshold PI .
Denote
c∗2 = γb+
2baK(R(4)0 − 1)
γ
,
c∗∗2 = γb+
baK(R(4)0 − 1)
γ
+
bαγ
aK(R
(4)
0 − 1)
,
We call c∗∗2 the elite control threshold EII , [21] which means the virus will be under
control when the immune intensity c is larger than c∗∗2 .
Denote another threshold
R(2)c = 1 +
√
α
K −√α.
For the positive parameters in model (5.1), we have the following lemmas.
Lemma 5.1 R(4)0 > R(2)c > 1⇔ c∗2 > c∗∗2 .
Proof.
c∗2 > c
∗∗
2 ⇔ baK(R
(4)
0 −1)
γ
> bαγ
aK(R(4)0 −1)
,
⇔ R(4)0 > R(2)c .

Lemma 5.2 (i) R(4)0 > R(2)c > 1⇔ c∗2 > c2; (ii) 1 < R(4)0 < R(2)c ⇔ c∗2 < c2.
Proof.
c∗2 > c2 ⇔ baK(R
(4)
0 −1)
γ
> b
√
α,
⇔ R(4)0 > R(2)c .
c∗2 < c2 ⇔ baK(R
(4)
0 −1)
γ
< b
√
α,
⇔ R(4)0 < R(2)c .

Lemma 5.3 (i) Assume 1 < R(4)0 < R(2)c . If R2−∗ > 1, then c > c∗∗2 ; (ii) Assume
R(4)0 > R(2)c > 1. If R2−∗ > 1, then c > c2.
Proof.
R2−∗ > 1 ⇔ γa (1− y
4−
∗
K
) > 1,
⇔
√
(γb− c)2 − 4αb2 > c− c∗2.
If c < c∗2 and one of conditions c < c1 or c > c2 is correct, then R2−∗ is always larger
than one. If c > c∗2, solving
√
(γb− c)2 − 4αb2 > c− c∗2, we have c > c∗∗2 . Thus,
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(i) If 1 < R(4)0 < R(2)c , then c∗2 < c2. From R2−∗ > 1, we have c > c∗∗2 .
(ii) If R(4)0 > R(2)c > 1, then c∗2 > c2. From R2−∗ > 1, we have c > c2. 
Lemma 5.4 (i) If 1 < R(4)0 < R(2)c , then R2+∗ > 1 has no solution; (ii) Assume
R(4)0 > R(2)c > 1. If R2+∗ > 1, then c2 < c < c∗∗2 .
Proof.
R2+∗ > 1 ⇔ γa (1− y
4+
∗
K
) > 1,
⇔ c∗ − c >√(γb− c)2 − 4αb2.
(i) If 1 < R
(4)
0 < R
(2)
c , then c∗2 < c2. Thus R2+∗ > 1 has no solution. (ii) If
R(4)0 > R(2)c > 1, then c∗2 > c2. Solving R2+∗ > 1, we have c2 < c < c∗∗2 . 
By Lemma 5.1 ∼ Lemma 5.4 and summing up the above analysis we obtain the
existing results of equilibria of system (5.1).
Theorem 5.1 (i) System (5.1) always exists an uninfected equilibrium E
(4)
0 = (0, 0);
(ii) If R(4)0 > 1, system (5.1) also has an immune-free equilibrium E(4)1 = (y(4)1 , 0),
where y
(4)
1 =
aK
γ
(R
(4)
0 − 1);
(iii) If 1 < R(4)0 < R(2)c and c > c∗∗2 , system (5.1) also has one positive equilibrium
E4−∗ ;
(iv) If R(4)0 > R(2)c > 1 and c2 < c < c∗∗2 , system (5.1) has two positive equilibria
E4+∗ and E
4−
∗ . While R(4)0 > R(2)c and c > c∗∗2 , system (5.1) only has one positive
equilibrium E4−∗ ;
The summary results of the existence for positive equilibria can be seen in Table 5
and Table 6.
5.1. Stability analysis
Let E˜ be any arbitrary equilibrium of system (5.1). The Jacobian matrix associated
with the system is
J4 =
[
γ − a− 2γ
K
y − pz −py
(α−y2)cz
(α+γy+y2)2
cy
α+γy+y2
− b
]
.
The characteristic equation of the linearized system of (5.1) at E˜ is given by |λI − J4| =
0.
Lemma 5.5 System (5.1) has no limit cycles in the interior of the first quadrant.
Proof. Consider the Dulac function
D2 =
1
yz
.
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We can get
∂(D2P2)
∂y
+
∂(D2Q2)
∂z
=
∂[ 1
yz
(γy(1− y
K
)− ay − pyz)]
∂y
+
∂[ 1
yz
( cyz
α+γy+y2
− bz)]
∂z
=
∂(γ
z
− γy
Kz
− a
z
− p)
∂y
+
∂( c
α+γy+y2
− b
y
)
∂z
= − γ
Kz
≤ 0.
By Bendixson-Dulac discriminant method, we know system (5.1) has no limit cycles.

Theorem 5.2 If R(4)0 < 1, then the uninfected equilibrium E(4)0 of system (5.1) is not
only locally asymptotically stable, but also global asymptotically stable. If R(4)0 > 1.
then the uninfected equilibrium E
(4)
0 of system (5.1) is unstable.
Proof. The characteristic equation of the linearized system of system (5.1) at E
(4)
0 is
(λ+ a− γ)(λ+ b) = 0.
Obviously, the characteristic roots −b and a(R(4)0 −1) are negative for R(4)0 < 1. Hence
E
(4)
0 is locally asymptotically stable. If R(4)0 > 1, then a(R(4)0 − 1) > 0, thus, the
uninfected equilibrium E
(4)
0 of system (5.1) is unstable. By Lemma 5.5, the uninfected
equilibrium E
(4)
0 is global asymptotically stable. Theorem 5.2 is proved. 
Theorem 5.3 If R(4)0 > 1 and 0 < c < c∗∗2 , then the immune-free equilibrium E(4)1 of
system (5.1) is not only locally asymptotically stable, but also global asymptotically
stable.
Proof. The characteristic equation of the linearized system of (5.1) at E
(4)
1 is given by
[λ− (γ − a− 2γ
K
y
(4)
1 )][λ− (
cy
(4)
1
α + γy
(4)
1 + (y
(4)
1 )
2
− b)] = 0,
we get two eigenvalues λ1 = γ − a − 2γK y(4)1 = a(1 − γa ) < 0 for R(4)0 > 1, and λ2 =
cy
(4)
1
α+γy
(4)
1 +(y
(4)
1 )
2
−b > 0 for 0 < c < c∗∗2 . Thus, the immune-free equilibrium E(4)1 of system
(5.1) is locally asymptotically stable for R(4)0 > 1 and 0 < c < c∗∗2 . By Lemma 5.5, the
immune-free equilibrium E
(4)
1 is global asymptotically stable. Theorem 5.3 is proved.

Theorem 5.4 (i) If (A.1) 1 < R(4)0 < R(2)c and c > c∗∗2 , or
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(A.2) R(4)0 > R(2)c and c > c2,
system (5.1) has an immune equilibrium E4−∗ , which is not only asymptotically stable,
but also global asymptotically stable.
(ii) If R(4)0 > R(2)c and c2 < c < c∗∗2 , system (5.1) also has an immune equilibrium
E4+∗ , which is an unstable saddle.
Proof. Denote E
(4)
∗ = (y
(4)
∗ , z
(4)
∗ ) as an arbitrary positive equilibrium of system (5.1).
The characteristic equation of the linearized system of (5.1) at the arbitrary positive
equilibrium E
(4)
∗ is given by
λ2 + b
(4)
1 λ+ b
(4)
2 = 0,
where
b
(4)
1 =
γ
K
y
(4)
∗ > 0,
b
(4)
2 =
α−(y(4)∗ )2
(α+γy
(4)
∗ +(y
(4)
∗ )2)2
pcy
(4)
∗ z
(4)
∗ .
For equilibrium E4−∗ ,
α− (y4−∗ )2 > 0 ⇔ −B−
√
B2−4αb2
2b
<
√
α,
⇔ c > c2.
If c > c2, we can get b
(4)
2 > 0, by Routh-Hurartz Criterion, we know in this case the
positive equilibrium E4−∗ is a stable node.
For equilibrium E4+∗ ,
α− (y4+∗ )2 < 0 ⇔ −B+
√
B2−4αb2
2b
>
√
α,
⇔ √B2 − 4αB2 > B + 2b√α.
If c2 < c < c
∗∗
2 , then b
(4)
2 < 0, so the immune equilibrium E
4+
∗ is an unstable saddle.
By Lemma 5.5, the immune equilibrium E4−∗ , is global asymptotically stable. Theorem
5.4 is proved. 
5.2. Saddle-node Bifurcation
If R(4)0 > R(2)c > 1 and c2−2γbc+γ2b2−4αb2 = 0, the immune equilibrium E4+∗ and
E4−∗ coincide with each other. Then system has the unique interior equilibrium E∗ =
(y∗, z∗) = (
√
α, a
pRc
(R0 −Rc)). The emergence and disappearance of the equilibrium is
due to the occurrence of saddle-node bifurcation when c crosses the bifurcation value
c[sn], where c[sn] = γb+ 2b
√
α.
Theorem 5.5 If R(4)0 > R(2)c > 1 and c = c[sn], system (5.1) will undergoes a saddle-
node bifurcation, c as the bifurcation parameter is given by c = c[sn] = γb+ 2b
√
α.
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Proof. We use Sotomayor’s theorem [26, 27, 28] to prove system (5.1) undergoes a
saddle-node bifurcation at c = c[sn]. It’s easy to prove Det[JE∗ ] = 0, so one of the
eigenvalue of the Jacobian at the saddle-node equilibrium is zero, where J = J4.
Let V = (V1, V2)
T and W = (W1,W2)
T represent the eigenvectors of JE∗ and
JTE∗ corresponding to the zero eigenvalue, respectively, then they are given by V =
(1,− γ
Kp
)T and W = (0, 1)T. Let F = (P2, Q2), we can get
Fc(E∗; c
[sn]) =
[
0
yz
α+γy+y2
]
(E∗;c[sn])
=

 0
γ(1−
√
α
K
)−a
p(2
√
α+γ)

 ,
and
D2F (E∗; c
[sn])(V, V )
=
[
0
−6cαyz+2czy3−2cαγz
(α+γy+y2)3
− 2γc(α−y2)
pK(α+γy+y2)2
]
(E∗;c[sn])
=
[
0
−2αz∗(γb+2b
√
α)(2
√
α+γ)
(α+γy∗+y2∗)3
]
.
Therefore,
Ω1 = W
TFc(E∗, c
[sn]) =
γ(1−
√
α
K
)− a
p(2
√
α+ γ)
6= 0,
Ω2 = W
T[D2F (E∗; c
[sn])(V, V )] =
−2αz∗(γb+ 2b
√
α)(2
√
α + γ)
(α + γy∗ + y2∗)2
6= 0.
Therefore, from the Sotomayor’ s theorem, [26, 27, 28] system (5.1) undergoes a
saddle-node bifurcation at E∗ = (y∗, z∗) when c = c[sn]. Hence, we can conclude that
when parameter c passes from one side from of c = c[sn] to the other side, the number
of interior equilibrium of system (5.1) changes from zero to two.

5.3. Transcritical Bifurcation
From the stability analysis of system (5.1), the boundary equilibrium E
(4)
1 looses its
stability at c = γb+
baK(R(4)0 −1)
γ
+ bαγ
aK(R(4)0 −1)
and one of the eigenvalue of the Jacobian
at E
(4)
1 is zero. Therefore, bifurcation may occur at the boundary equilibrium E
(4)
1 . In
this section, we select parameter c as bifurcation parameter to study the existence of
a transcritical bifurcation.
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Theorem 5.6 If R0 > 1 and c = c
[tc], system (5.1) will undergoes a transcritical
bifurcation between E
(4)
1 and E
4−
∗ , c as the bifurcation parameter is given by c = c
[tc] =
γb+
baK(R
(4)
0 −1)
γ
+ bαγ
aK(R
(4)
0 −1)
.
Proof. We use Sotomayor’s theorem [26, 27, 28] to prove system (5.1) undergoes a
transcritical bifurcation. Obviously, one of the eigenvalue of the Jacobian at E
(4)
1 is
zero, if and only if c = c[tc].
Let ν = (ν1, ν2)
T and ω = (ω1, ω2)
T denote the eigenvectors of J
E
(4)
1
and JT
E
(4)
1
corresponding to the zero eigenvalue, respectively, we can get ν = (1,− γ
Kp
)T and
ω = (0, 1)T, Besides,
Fc(E
(4)
1 ; c
[tc]) =
[
0
yz
α+γy+y2
]
(E
(4)
1 ;c
[tc])
=
[
0
0
]
.
DFc(E
(4)
1 ; c
[tc])ν
=
[
0
αz−zy2
(α+γy+y2)2
− γy
Kp(α+γy+y2)
]
(E
(4)
1 ;c
[tc])
=

 0
− γy
(4)
1
Kp(α+γy
(4)
1 +y
(4)
1
2
)

 .
D2F (E
(4)
1 ; c
[tc])(ν, ν)
=
[
0
−6cαyz+2czy3−2cαγz
(α+γy+y2)3
− 2γc(α−y2)
pK(α+γy+y2)2
]
(E
(4)
1 ;c
[tc])
=


0
−2γ(γb+ baK(R
(4)
0 −1)
r
+ bαr
aK(R
(4)
0
−1)
)(α−y(4)1
2
)
(α+γy
(4)
1 +y
(4)
1
2
)2

 .
Therefore,
Φ1 = ω
TFc(E
(4)
1 ; c
[tc]) = 0,
Φ2 = ω
T[DFc(E
(4)
1 ; c
[tc])η] = − γy
(4)
1
Kp(α + γy
(4)
1 + y
(4)
1
2
)
6= 0
Φ3 = ω
T[D2F (E
(4)
1 ; c
[tc])(ν, ν)] =
−2γ(γb+ baK(R
(4)
0 −1)
γ
+ bαγ
aK(R
(4)
0 −1)
)(α− y(4)1
2
)
(α + γy
(4)
1 + y
(4)
1
2
)2
6= 0.
Therefore, system (5.1) will undergoes a transcritical bifurcation between E
(4)
1 and
E4−∗ at c = c
[tc]
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Remark 5.1 If R(4)0 > R(4)c > 1 and c2 < c < c∗∗2 , system (5.1) has bistability
appear. In other cases, system (5.1) has no bistability appear. Threshold c2 is the
post-treatment control threshold, c∗∗2 is the elite control threshold. (c2, c
∗∗
2 ) is the
bistable interval. 
To sum up, the stabilities of the equilibria and the behaviors of system (5.1) can
be shown in Table 7 and Table 8.
5.4. Numerical simulations and discussion
To verify our analysis results, we carry out some numerical simulations choosing
some parameter values shown as in [? 25]:
γ = 6 day−1, K = 6 cells/µl, a = 3 day−1,
p = 1 day−1, α = 1 cells/µl, γ = 0.5 cells/µl,
b = 1 day−1.
(5.1)
The parameters chose as same as in (5.1), the thresholds R(4)0 = 2.0000, R(2)c =
1.2000, post-treatment control threshold c2 = 2.5000 and elite control threshold c
∗∗
2 ≈
3.5278. In this case, R(4)0 > R(2)c and c2 < c∗∗2 , then we get a bistable interval
(2.5000, 3.8333)(see Figure 5). When 0 < c < c2, the immune-free equilibrium E
(4)
1
is stable (see Fig. 7); When c2 < c < c
∗∗
2 , the immune-free equilibrium E
(4)
1 and the
positive equilibrium E4−∗ are stable (see Fig. 6); When c > c
∗∗
2 , only the positive
equilibrium E4−∗ is stable (see Figure 7).
6. Discussion
In this paper, we have considered the 2-dimensional, 3-dimensional monotonic and
nonmonotonic immune response in viral infection system. For viral infection system
with monotonic immune response, by analyzing the existence and stability of the equi-
libria of the viral infection system with monotonic immune response, we find that the
system with monotonic immune response has no bistability appear. Beside, we discuss
the viral infection system with nonmonotonic immune response, and chose Monod-
Haldane function as the nonmonotonic immune response. For viral infection system
with nonmonotonic immune response, we find the system has bistability appear under
some conditions. Through calculations, we got two important threshold. We call them
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Figure 5: Bistability and saddle-node bifurcation diagram of system (1). The solid line is the
stable virus and the dashed line depends the unstable virus. The post-treatment control threshold is
c2 = 2.5000, the elite control threshold is c
∗∗
2 ≈ 3.5278 and the bistable interval is (2.5000, 3.5278).
c = 3 day−1 and other parameter values are shown in (5.1).
Figure 6: System (1) has two different stable equilibria E(4)1 and E
4−
∗
. Parameter c = 3 day−1
and other parameter values are shown in (5.1). We choose different initial values.
post-treatment control threshold and elite control threshold. Below the post-treatment
control threshold, the system has a stable immune-free steady state, which means the
viral will be rebound. Above the elite control threshold, the system has a stable posi-
tive equilibrium, which indicates that the virus will be under control. While between
the two thresholds is a bistable interval, the system can have bistability appear, which
imply that the patients either experience viral rebound after treatment or achieve the
post-treatment control. Select the rate of immune cells stimulated by the viruses as
a bifurcation parameter for 2-dimensional and 3-dimensional nonmonotonic immune
responses, we prove the system exhibits saddle-node bifurcation and transcritical bi-
furcation. The numerical simulations can help us test the results of analysis and better
understand the model.
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Figure 7: (A) Choosing c = 2 day−1, less than the post-treatment control threshold c2 = 2.5000,
system (5.1) only has a stable equilibrium E
(4)
1 ; (B) While choosing c = 4 day
−1, larger than the
elite control threshold c∗∗2 ≈ 3.5278, system (5.1) only has the stable equilibria E4−∗ . Other parameter
values are shown in (5.1).
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